Global Viral Vector Production (Research-use) Market Research Report 2024(Status and Outlook)
Report Overview:
Viral vectors are increasingly being employed in ongoing clinical trials owing to their efficiency in gene delivery. Significant advancements in delivery vectors that have resulted in the increased therapeutic efficacy of such vectors for gene delivery are driving the market for viral vector production (research-use). Amongst all viral vectors, lentivirus, adeno-associated virus, and adenovirus are the most used vectors across research settings.
The Global Viral Vector Production (Research-use) Market Size was estimated at USD 1302.72 million in 2023 and is projected to reach USD 3662.27 million by 2029, exhibiting a CAGR of 18.80% during the forecast period.
This report provides a deep insight into the global Viral Vector Production (Research-use) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector Production (Research-use) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector Production (Research-use) market in any manner.
Global Viral Vector Production (Research-use) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra Biologics Ltd.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Novasep Holding S.A.S
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Vigene Biosciences, Inc.
General Electric Company (GE Healthcare)
CEVEC Pharmaceuticals GmbH
Batavia Biosciences B.V.
Biovion oy
Wuxi AppTec Co., Ltd.
VGXI, Inc.
Catalent Inc.
Miltenyi Biotec GmbH
SIRION Biotech GmbH
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Creative Biogene
Vibalogics GmbH
Takara Bio.
Cell and Gene Therapy Catapult
BlueBird Bio
Addgene, Inc.
Aldevron, L.L.C.
Audentes Therapeutics
BioMarin Pharmaceutical
RegenxBio, Inc.
Market Segmentation (by Type)
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others
Market Segmentation (by Application)
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector Production (Research-use) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Viral vectors are increasingly being employed in ongoing clinical trials owing to their efficiency in gene delivery. Significant advancements in delivery vectors that have resulted in the increased therapeutic efficacy of such vectors for gene delivery are driving the market for viral vector production (research-use). Amongst all viral vectors, lentivirus, adeno-associated virus, and adenovirus are the most used vectors across research settings.
The Global Viral Vector Production (Research-use) Market Size was estimated at USD 1302.72 million in 2023 and is projected to reach USD 3662.27 million by 2029, exhibiting a CAGR of 18.80% during the forecast period.
This report provides a deep insight into the global Viral Vector Production (Research-use) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vector Production (Research-use) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vector Production (Research-use) market in any manner.
Global Viral Vector Production (Research-use) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck KGaA
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Cobra Biologics Ltd.
Thermo Fisher Scientific
Waisman Biomanufacturing
Genezen
YPOSKESI
Advanced BioScience Laboratories, Inc. (ABL, Inc.)
Novasep Holding S.A.S
Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
Vigene Biosciences, Inc.
General Electric Company (GE Healthcare)
CEVEC Pharmaceuticals GmbH
Batavia Biosciences B.V.
Biovion oy
Wuxi AppTec Co., Ltd.
VGXI, Inc.
Catalent Inc.
Miltenyi Biotec GmbH
SIRION Biotech GmbH
Virovek Incorporation
BioNTech IMFS GmbH
VIVEbiotech S.L.
Creative Biogene
Vibalogics GmbH
Takara Bio.
Cell and Gene Therapy Catapult
BlueBird Bio
Addgene, Inc.
Aldevron, L.L.C.
Audentes Therapeutics
BioMarin Pharmaceutical
RegenxBio, Inc.
Market Segmentation (by Type)
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Others
Market Segmentation (by Application)
Cell & Gene Therapy Development
Vaccine Development
Biopharmaceutical and Pharmaceutical Discovery
Biomedical Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viral Vector Production (Research-use) Market
- Overview of the regional outlook of the Viral Vector Production (Research-use) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vector Production (Research-use) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Vector Production (Research-use)
1.2 Key Market Segments
1.2.1 Viral Vector Production (Research-use) Segment by Type
1.2.2 Viral Vector Production (Research-use) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector Production (Research-use) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vector Production (Research-use) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Vector Production (Research-use) Sales by Manufacturers (2019-2024)
3.2 Global Viral Vector Production (Research-use) Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vector Production (Research-use) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vector Production (Research-use) Sales Sites, Area Served, Product Type
3.6 Viral Vector Production (Research-use) Market Competitive Situation and Trends
3.6.1 Viral Vector Production (Research-use) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vector Production (Research-use) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR PRODUCTION (RESEARCH-USE) INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector Production (Research-use) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector Production (Research-use) Sales Market Share by Type (2019-2024)
6.3 Global Viral Vector Production (Research-use) Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vector Production (Research-use) Price by Type (2019-2024)
7 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector Production (Research-use) Market Sales by Application (2019-2024)
7.3 Global Viral Vector Production (Research-use) Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
8 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY REGION
8.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.2 Global Viral Vector Production (Research-use) Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vector Production (Research-use) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector Production (Research-use) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector Production (Research-use) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector Production (Research-use) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector Production (Research-use) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck KGaA
9.1.1 Merck KGaA Viral Vector Production (Research-use) Basic Information
9.1.2 Merck KGaA Viral Vector Production (Research-use) Product Overview
9.1.3 Merck KGaA Viral Vector Production (Research-use) Product Market Performance
9.1.4 Merck KGaA Business Overview
9.1.5 Merck KGaA Viral Vector Production (Research-use) SWOT Analysis
9.1.6 Merck KGaA Recent Developments
9.2 Lonza
9.2.1 Lonza Viral Vector Production (Research-use) Basic Information
9.2.2 Lonza Viral Vector Production (Research-use) Product Overview
9.2.3 Lonza Viral Vector Production (Research-use) Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Viral Vector Production (Research-use) SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Basic Information
9.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Overview
9.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Market Performance
9.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) SWOT Analysis
9.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
9.3.6 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
9.4 Cobra Biologics Ltd.
9.4.1 Cobra Biologics Ltd. Viral Vector Production (Research-use) Basic Information
9.4.2 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Overview
9.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Market Performance
9.4.4 Cobra Biologics Ltd. Business Overview
9.4.5 Cobra Biologics Ltd. Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Viral Vector Production (Research-use) Basic Information
9.5.2 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Overview
9.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Market Performance
9.5.4 Thermo Fisher Scientific Business Overview
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 Waisman Biomanufacturing
9.6.1 Waisman Biomanufacturing Viral Vector Production (Research-use) Basic Information
9.6.2 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Overview
9.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Market Performance
9.6.4 Waisman Biomanufacturing Business Overview
9.6.5 Waisman Biomanufacturing Recent Developments
9.7 Genezen
9.7.1 Genezen Viral Vector Production (Research-use) Basic Information
9.7.2 Genezen Viral Vector Production (Research-use) Product Overview
9.7.3 Genezen Viral Vector Production (Research-use) Product Market Performance
9.7.4 Genezen Business Overview
9.7.5 Genezen Recent Developments
9.8 YPOSKESI
9.8.1 YPOSKESI Viral Vector Production (Research-use) Basic Information
9.8.2 YPOSKESI Viral Vector Production (Research-use) Product Overview
9.8.3 YPOSKESI Viral Vector Production (Research-use) Product Market Performance
9.8.4 YPOSKESI Business Overview
9.8.5 YPOSKESI Recent Developments
9.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
9.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Basic Information
9.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Overview
9.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Market Performance
9.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
9.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
9.10 Novasep Holding S.A.S
9.10.1 Novasep Holding S.A.S Viral Vector Production (Research-use) Basic Information
9.10.2 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Overview
9.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Market Performance
9.10.4 Novasep Holding S.A.S Business Overview
9.10.5 Novasep Holding S.A.S Recent Developments
9.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
9.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Basic Information
9.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Overview
9.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Market Performance
9.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
9.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
9.12 Vigene Biosciences, Inc.
9.12.1 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Basic Information
9.12.2 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Overview
9.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Market Performance
9.12.4 Vigene Biosciences, Inc. Business Overview
9.12.5 Vigene Biosciences, Inc. Recent Developments
9.13 General Electric Company (GE Healthcare)
9.13.1 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Basic Information
9.13.2 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Overview
9.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Market Performance
9.13.4 General Electric Company (GE Healthcare) Business Overview
9.13.5 General Electric Company (GE Healthcare) Recent Developments
9.14 CEVEC Pharmaceuticals GmbH
9.14.1 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Basic Information
9.14.2 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Overview
9.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Market Performance
9.14.4 CEVEC Pharmaceuticals GmbH Business Overview
9.14.5 CEVEC Pharmaceuticals GmbH Recent Developments
9.15 Batavia Biosciences B.V.
9.15.1 Batavia Biosciences B.V. Viral Vector Production (Research-use) Basic Information
9.15.2 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Overview
9.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Market Performance
9.15.4 Batavia Biosciences B.V. Business Overview
9.15.5 Batavia Biosciences B.V. Recent Developments
9.16 Biovion oy
9.16.1 Biovion oy Viral Vector Production (Research-use) Basic Information
9.16.2 Biovion oy Viral Vector Production (Research-use) Product Overview
9.16.3 Biovion oy Viral Vector Production (Research-use) Product Market Performance
9.16.4 Biovion oy Business Overview
9.16.5 Biovion oy Recent Developments
9.17 Wuxi AppTec Co., Ltd.
9.17.1 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Basic Information
9.17.2 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Overview
9.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Market Performance
9.17.4 Wuxi AppTec Co., Ltd. Business Overview
9.17.5 Wuxi AppTec Co., Ltd. Recent Developments
9.18 VGXI, Inc.
9.18.1 VGXI, Inc. Viral Vector Production (Research-use) Basic Information
9.18.2 VGXI, Inc. Viral Vector Production (Research-use) Product Overview
9.18.3 VGXI, Inc. Viral Vector Production (Research-use) Product Market Performance
9.18.4 VGXI, Inc. Business Overview
9.18.5 VGXI, Inc. Recent Developments
9.19 Catalent Inc.
9.19.1 Catalent Inc. Viral Vector Production (Research-use) Basic Information
9.19.2 Catalent Inc. Viral Vector Production (Research-use) Product Overview
9.19.3 Catalent Inc. Viral Vector Production (Research-use) Product Market Performance
9.19.4 Catalent Inc. Business Overview
9.19.5 Catalent Inc. Recent Developments
9.20 Miltenyi Biotec GmbH
9.20.1 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Basic Information
9.20.2 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Overview
9.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Market Performance
9.20.4 Miltenyi Biotec GmbH Business Overview
9.20.5 Miltenyi Biotec GmbH Recent Developments
9.21 SIRION Biotech GmbH
9.21.1 SIRION Biotech GmbH Viral Vector Production (Research-use) Basic Information
9.21.2 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Overview
9.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Market Performance
9.21.4 SIRION Biotech GmbH Business Overview
9.21.5 SIRION Biotech GmbH Recent Developments
9.22 Virovek Incorporation
9.22.1 Virovek Incorporation Viral Vector Production (Research-use) Basic Information
9.22.2 Virovek Incorporation Viral Vector Production (Research-use) Product Overview
9.22.3 Virovek Incorporation Viral Vector Production (Research-use) Product Market Performance
9.22.4 Virovek Incorporation Business Overview
9.22.5 Virovek Incorporation Recent Developments
9.23 BioNTech IMFS GmbH
9.23.1 BioNTech IMFS GmbH Viral Vector Production (Research-use) Basic Information
9.23.2 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Overview
9.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Market Performance
9.23.4 BioNTech IMFS GmbH Business Overview
9.23.5 BioNTech IMFS GmbH Recent Developments
9.24 VIVEbiotech S.L.
9.24.1 VIVEbiotech S.L. Viral Vector Production (Research-use) Basic Information
9.24.2 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Overview
9.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Market Performance
9.24.4 VIVEbiotech S.L. Business Overview
9.24.5 VIVEbiotech S.L. Recent Developments
9.25 Creative Biogene
9.25.1 Creative Biogene Viral Vector Production (Research-use) Basic Information
9.25.2 Creative Biogene Viral Vector Production (Research-use) Product Overview
9.25.3 Creative Biogene Viral Vector Production (Research-use) Product Market Performance
9.25.4 Creative Biogene Business Overview
9.25.5 Creative Biogene Recent Developments
9.26 Vibalogics GmbH
9.26.1 Vibalogics GmbH Viral Vector Production (Research-use) Basic Information
9.26.2 Vibalogics GmbH Viral Vector Production (Research-use) Product Overview
9.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Product Market Performance
9.26.4 Vibalogics GmbH Business Overview
9.26.5 Vibalogics GmbH Recent Developments
9.27 Takara Bio.
9.27.1 Takara Bio. Viral Vector Production (Research-use) Basic Information
9.27.2 Takara Bio. Viral Vector Production (Research-use) Product Overview
9.27.3 Takara Bio. Viral Vector Production (Research-use) Product Market Performance
9.27.4 Takara Bio. Business Overview
9.27.5 Takara Bio. Recent Developments
9.28 Cell and Gene Therapy Catapult
9.28.1 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Basic Information
9.28.2 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Overview
9.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Market Performance
9.28.4 Cell and Gene Therapy Catapult Business Overview
9.28.5 Cell and Gene Therapy Catapult Recent Developments
9.29 BlueBird Bio
9.29.1 BlueBird Bio Viral Vector Production (Research-use) Basic Information
9.29.2 BlueBird Bio Viral Vector Production (Research-use) Product Overview
9.29.3 BlueBird Bio Viral Vector Production (Research-use) Product Market Performance
9.29.4 BlueBird Bio Business Overview
9.29.5 BlueBird Bio Recent Developments
9.30 Addgene, Inc.
9.30.1 Addgene, Inc. Viral Vector Production (Research-use) Basic Information
9.30.2 Addgene, Inc. Viral Vector Production (Research-use) Product Overview
9.30.3 Addgene, Inc. Viral Vector Production (Research-use) Product Market Performance
9.30.4 Addgene, Inc. Business Overview
9.30.5 Addgene, Inc. Recent Developments
10 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET FORECAST BY REGION
10.1 Global Viral Vector Production (Research-use) Market Size Forecast
10.2 Global Viral Vector Production (Research-use) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector Production (Research-use) Market Size Forecast by Region
10.2.4 South America Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector Production (Research-use) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Vector Production (Research-use) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vector Production (Research-use) by Type (2025-2030)
11.1.2 Global Viral Vector Production (Research-use) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vector Production (Research-use) by Type (2025-2030)
11.2 Global Viral Vector Production (Research-use) Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vector Production (Research-use) Sales (K Units) Forecast by Application
11.2.2 Global Viral Vector Production (Research-use) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Vector Production (Research-use)
1.2 Key Market Segments
1.2.1 Viral Vector Production (Research-use) Segment by Type
1.2.2 Viral Vector Production (Research-use) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Vector Production (Research-use) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vector Production (Research-use) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Vector Production (Research-use) Sales by Manufacturers (2019-2024)
3.2 Global Viral Vector Production (Research-use) Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vector Production (Research-use) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vector Production (Research-use) Sales Sites, Area Served, Product Type
3.6 Viral Vector Production (Research-use) Market Competitive Situation and Trends
3.6.1 Viral Vector Production (Research-use) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vector Production (Research-use) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL VECTOR PRODUCTION (RESEARCH-USE) INDUSTRY CHAIN ANALYSIS
4.1 Viral Vector Production (Research-use) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector Production (Research-use) Sales Market Share by Type (2019-2024)
6.3 Global Viral Vector Production (Research-use) Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vector Production (Research-use) Price by Type (2019-2024)
7 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector Production (Research-use) Market Sales by Application (2019-2024)
7.3 Global Viral Vector Production (Research-use) Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
8 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET SEGMENTATION BY REGION
8.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.1 Global Viral Vector Production (Research-use) Sales by Region
8.1.2 Global Viral Vector Production (Research-use) Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vector Production (Research-use) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector Production (Research-use) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector Production (Research-use) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector Production (Research-use) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector Production (Research-use) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck KGaA
9.1.1 Merck KGaA Viral Vector Production (Research-use) Basic Information
9.1.2 Merck KGaA Viral Vector Production (Research-use) Product Overview
9.1.3 Merck KGaA Viral Vector Production (Research-use) Product Market Performance
9.1.4 Merck KGaA Business Overview
9.1.5 Merck KGaA Viral Vector Production (Research-use) SWOT Analysis
9.1.6 Merck KGaA Recent Developments
9.2 Lonza
9.2.1 Lonza Viral Vector Production (Research-use) Basic Information
9.2.2 Lonza Viral Vector Production (Research-use) Product Overview
9.2.3 Lonza Viral Vector Production (Research-use) Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Viral Vector Production (Research-use) SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.3.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Basic Information
9.3.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Overview
9.3.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Market Performance
9.3.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) SWOT Analysis
9.3.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
9.3.6 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
9.4 Cobra Biologics Ltd.
9.4.1 Cobra Biologics Ltd. Viral Vector Production (Research-use) Basic Information
9.4.2 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Overview
9.4.3 Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Market Performance
9.4.4 Cobra Biologics Ltd. Business Overview
9.4.5 Cobra Biologics Ltd. Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Viral Vector Production (Research-use) Basic Information
9.5.2 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Overview
9.5.3 Thermo Fisher Scientific Viral Vector Production (Research-use) Product Market Performance
9.5.4 Thermo Fisher Scientific Business Overview
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 Waisman Biomanufacturing
9.6.1 Waisman Biomanufacturing Viral Vector Production (Research-use) Basic Information
9.6.2 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Overview
9.6.3 Waisman Biomanufacturing Viral Vector Production (Research-use) Product Market Performance
9.6.4 Waisman Biomanufacturing Business Overview
9.6.5 Waisman Biomanufacturing Recent Developments
9.7 Genezen
9.7.1 Genezen Viral Vector Production (Research-use) Basic Information
9.7.2 Genezen Viral Vector Production (Research-use) Product Overview
9.7.3 Genezen Viral Vector Production (Research-use) Product Market Performance
9.7.4 Genezen Business Overview
9.7.5 Genezen Recent Developments
9.8 YPOSKESI
9.8.1 YPOSKESI Viral Vector Production (Research-use) Basic Information
9.8.2 YPOSKESI Viral Vector Production (Research-use) Product Overview
9.8.3 YPOSKESI Viral Vector Production (Research-use) Product Market Performance
9.8.4 YPOSKESI Business Overview
9.8.5 YPOSKESI Recent Developments
9.9 Advanced BioScience Laboratories, Inc. (ABL, Inc.)
9.9.1 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Basic Information
9.9.2 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Overview
9.9.3 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Market Performance
9.9.4 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
9.9.5 Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
9.10 Novasep Holding S.A.S
9.10.1 Novasep Holding S.A.S Viral Vector Production (Research-use) Basic Information
9.10.2 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Overview
9.10.3 Novasep Holding S.A.S Viral Vector Production (Research-use) Product Market Performance
9.10.4 Novasep Holding S.A.S Business Overview
9.10.5 Novasep Holding S.A.S Recent Developments
9.11 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.)
9.11.1 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Basic Information
9.11.2 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Overview
9.11.3 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Market Performance
9.11.4 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
9.11.5 Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
9.12 Vigene Biosciences, Inc.
9.12.1 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Basic Information
9.12.2 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Overview
9.12.3 Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Market Performance
9.12.4 Vigene Biosciences, Inc. Business Overview
9.12.5 Vigene Biosciences, Inc. Recent Developments
9.13 General Electric Company (GE Healthcare)
9.13.1 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Basic Information
9.13.2 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Overview
9.13.3 General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Market Performance
9.13.4 General Electric Company (GE Healthcare) Business Overview
9.13.5 General Electric Company (GE Healthcare) Recent Developments
9.14 CEVEC Pharmaceuticals GmbH
9.14.1 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Basic Information
9.14.2 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Overview
9.14.3 CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Market Performance
9.14.4 CEVEC Pharmaceuticals GmbH Business Overview
9.14.5 CEVEC Pharmaceuticals GmbH Recent Developments
9.15 Batavia Biosciences B.V.
9.15.1 Batavia Biosciences B.V. Viral Vector Production (Research-use) Basic Information
9.15.2 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Overview
9.15.3 Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Market Performance
9.15.4 Batavia Biosciences B.V. Business Overview
9.15.5 Batavia Biosciences B.V. Recent Developments
9.16 Biovion oy
9.16.1 Biovion oy Viral Vector Production (Research-use) Basic Information
9.16.2 Biovion oy Viral Vector Production (Research-use) Product Overview
9.16.3 Biovion oy Viral Vector Production (Research-use) Product Market Performance
9.16.4 Biovion oy Business Overview
9.16.5 Biovion oy Recent Developments
9.17 Wuxi AppTec Co., Ltd.
9.17.1 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Basic Information
9.17.2 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Overview
9.17.3 Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Market Performance
9.17.4 Wuxi AppTec Co., Ltd. Business Overview
9.17.5 Wuxi AppTec Co., Ltd. Recent Developments
9.18 VGXI, Inc.
9.18.1 VGXI, Inc. Viral Vector Production (Research-use) Basic Information
9.18.2 VGXI, Inc. Viral Vector Production (Research-use) Product Overview
9.18.3 VGXI, Inc. Viral Vector Production (Research-use) Product Market Performance
9.18.4 VGXI, Inc. Business Overview
9.18.5 VGXI, Inc. Recent Developments
9.19 Catalent Inc.
9.19.1 Catalent Inc. Viral Vector Production (Research-use) Basic Information
9.19.2 Catalent Inc. Viral Vector Production (Research-use) Product Overview
9.19.3 Catalent Inc. Viral Vector Production (Research-use) Product Market Performance
9.19.4 Catalent Inc. Business Overview
9.19.5 Catalent Inc. Recent Developments
9.20 Miltenyi Biotec GmbH
9.20.1 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Basic Information
9.20.2 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Overview
9.20.3 Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Market Performance
9.20.4 Miltenyi Biotec GmbH Business Overview
9.20.5 Miltenyi Biotec GmbH Recent Developments
9.21 SIRION Biotech GmbH
9.21.1 SIRION Biotech GmbH Viral Vector Production (Research-use) Basic Information
9.21.2 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Overview
9.21.3 SIRION Biotech GmbH Viral Vector Production (Research-use) Product Market Performance
9.21.4 SIRION Biotech GmbH Business Overview
9.21.5 SIRION Biotech GmbH Recent Developments
9.22 Virovek Incorporation
9.22.1 Virovek Incorporation Viral Vector Production (Research-use) Basic Information
9.22.2 Virovek Incorporation Viral Vector Production (Research-use) Product Overview
9.22.3 Virovek Incorporation Viral Vector Production (Research-use) Product Market Performance
9.22.4 Virovek Incorporation Business Overview
9.22.5 Virovek Incorporation Recent Developments
9.23 BioNTech IMFS GmbH
9.23.1 BioNTech IMFS GmbH Viral Vector Production (Research-use) Basic Information
9.23.2 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Overview
9.23.3 BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Market Performance
9.23.4 BioNTech IMFS GmbH Business Overview
9.23.5 BioNTech IMFS GmbH Recent Developments
9.24 VIVEbiotech S.L.
9.24.1 VIVEbiotech S.L. Viral Vector Production (Research-use) Basic Information
9.24.2 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Overview
9.24.3 VIVEbiotech S.L. Viral Vector Production (Research-use) Product Market Performance
9.24.4 VIVEbiotech S.L. Business Overview
9.24.5 VIVEbiotech S.L. Recent Developments
9.25 Creative Biogene
9.25.1 Creative Biogene Viral Vector Production (Research-use) Basic Information
9.25.2 Creative Biogene Viral Vector Production (Research-use) Product Overview
9.25.3 Creative Biogene Viral Vector Production (Research-use) Product Market Performance
9.25.4 Creative Biogene Business Overview
9.25.5 Creative Biogene Recent Developments
9.26 Vibalogics GmbH
9.26.1 Vibalogics GmbH Viral Vector Production (Research-use) Basic Information
9.26.2 Vibalogics GmbH Viral Vector Production (Research-use) Product Overview
9.26.3 Vibalogics GmbH Viral Vector Production (Research-use) Product Market Performance
9.26.4 Vibalogics GmbH Business Overview
9.26.5 Vibalogics GmbH Recent Developments
9.27 Takara Bio.
9.27.1 Takara Bio. Viral Vector Production (Research-use) Basic Information
9.27.2 Takara Bio. Viral Vector Production (Research-use) Product Overview
9.27.3 Takara Bio. Viral Vector Production (Research-use) Product Market Performance
9.27.4 Takara Bio. Business Overview
9.27.5 Takara Bio. Recent Developments
9.28 Cell and Gene Therapy Catapult
9.28.1 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Basic Information
9.28.2 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Overview
9.28.3 Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Market Performance
9.28.4 Cell and Gene Therapy Catapult Business Overview
9.28.5 Cell and Gene Therapy Catapult Recent Developments
9.29 BlueBird Bio
9.29.1 BlueBird Bio Viral Vector Production (Research-use) Basic Information
9.29.2 BlueBird Bio Viral Vector Production (Research-use) Product Overview
9.29.3 BlueBird Bio Viral Vector Production (Research-use) Product Market Performance
9.29.4 BlueBird Bio Business Overview
9.29.5 BlueBird Bio Recent Developments
9.30 Addgene, Inc.
9.30.1 Addgene, Inc. Viral Vector Production (Research-use) Basic Information
9.30.2 Addgene, Inc. Viral Vector Production (Research-use) Product Overview
9.30.3 Addgene, Inc. Viral Vector Production (Research-use) Product Market Performance
9.30.4 Addgene, Inc. Business Overview
9.30.5 Addgene, Inc. Recent Developments
10 VIRAL VECTOR PRODUCTION (RESEARCH-USE) MARKET FORECAST BY REGION
10.1 Global Viral Vector Production (Research-use) Market Size Forecast
10.2 Global Viral Vector Production (Research-use) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector Production (Research-use) Market Size Forecast by Region
10.2.4 South America Viral Vector Production (Research-use) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector Production (Research-use) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Vector Production (Research-use) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vector Production (Research-use) by Type (2025-2030)
11.1.2 Global Viral Vector Production (Research-use) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vector Production (Research-use) by Type (2025-2030)
11.2 Global Viral Vector Production (Research-use) Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vector Production (Research-use) Sales (K Units) Forecast by Application
11.2.2 Global Viral Vector Production (Research-use) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Vector Production (Research-use) Market Size Comparison by Region (M USD)
Table 5. Global Viral Vector Production (Research-use) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viral Vector Production (Research-use) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Vector Production (Research-use) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Vector Production (Research-use) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2022)
Table 10. Global Market Viral Vector Production (Research-use) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Vector Production (Research-use) Sales Sites and Area Served
Table 12. Manufacturers Viral Vector Production (Research-use) Product Type
Table 13. Global Viral Vector Production (Research-use) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Vector Production (Research-use)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector Production (Research-use) Market Challenges
Table 22. Global Viral Vector Production (Research-use) Sales by Type (K Units)
Table 23. Global Viral Vector Production (Research-use) Market Size by Type (M USD)
Table 24. Global Viral Vector Production (Research-use) Sales (K Units) by Type (2019-2024)
Table 25. Global Viral Vector Production (Research-use) Sales Market Share by Type (2019-2024)
Table 26. Global Viral Vector Production (Research-use) Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Vector Production (Research-use) Market Size Share by Type (2019-2024)
Table 28. Global Viral Vector Production (Research-use) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viral Vector Production (Research-use) Sales (K Units) by Application
Table 30. Global Viral Vector Production (Research-use) Market Size by Application
Table 31. Global Viral Vector Production (Research-use) Sales by Application (2019-2024) & (K Units)
Table 32. Global Viral Vector Production (Research-use) Sales Market Share by Application (2019-2024)
Table 33. Global Viral Vector Production (Research-use) Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Vector Production (Research-use) Market Share by Application (2019-2024)
Table 35. Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 37. Global Viral Vector Production (Research-use) Sales Market Share by Region (2019-2024)
Table 38. North America Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 41. South America Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 43. Merck KGaA Viral Vector Production (Research-use) Basic Information
Table 44. Merck KGaA Viral Vector Production (Research-use) Product Overview
Table 45. Merck KGaA Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck KGaA Business Overview
Table 47. Merck KGaA Viral Vector Production (Research-use) SWOT Analysis
Table 48. Merck KGaA Recent Developments
Table 49. Lonza Viral Vector Production (Research-use) Basic Information
Table 50. Lonza Viral Vector Production (Research-use) Product Overview
Table 51. Lonza Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Business Overview
Table 53. Lonza Viral Vector Production (Research-use) SWOT Analysis
Table 54. Lonza Recent Developments
Table 55. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Basic Information
Table 56. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Overview
Table 57. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) SWOT Analysis
Table 59. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
Table 61. Cobra Biologics Ltd. Viral Vector Production (Research-use) Basic Information
Table 62. Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Overview
Table 63. Cobra Biologics Ltd. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cobra Biologics Ltd. Business Overview
Table 65. Cobra Biologics Ltd. Recent Developments
Table 66. Thermo Fisher Scientific Viral Vector Production (Research-use) Basic Information
Table 67. Thermo Fisher Scientific Viral Vector Production (Research-use) Product Overview
Table 68. Thermo Fisher Scientific Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Waisman Biomanufacturing Viral Vector Production (Research-use) Basic Information
Table 72. Waisman Biomanufacturing Viral Vector Production (Research-use) Product Overview
Table 73. Waisman Biomanufacturing Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Waisman Biomanufacturing Business Overview
Table 75. Waisman Biomanufacturing Recent Developments
Table 76. Genezen Viral Vector Production (Research-use) Basic Information
Table 77. Genezen Viral Vector Production (Research-use) Product Overview
Table 78. Genezen Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Genezen Business Overview
Table 80. Genezen Recent Developments
Table 81. YPOSKESI Viral Vector Production (Research-use) Basic Information
Table 82. YPOSKESI Viral Vector Production (Research-use) Product Overview
Table 83. YPOSKESI Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. YPOSKESI Business Overview
Table 85. YPOSKESI Recent Developments
Table 86. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Basic Information
Table 87. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Overview
Table 88. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
Table 90. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
Table 91. Novasep Holding S.A.S Viral Vector Production (Research-use) Basic Information
Table 92. Novasep Holding S.A.S Viral Vector Production (Research-use) Product Overview
Table 93. Novasep Holding S.A.S Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novasep Holding S.A.S Business Overview
Table 95. Novasep Holding S.A.S Recent Developments
Table 96. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Basic Information
Table 97. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Overview
Table 98. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
Table 100. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
Table 101. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Basic Information
Table 102. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Overview
Table 103. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Vigene Biosciences, Inc. Business Overview
Table 105. Vigene Biosciences, Inc. Recent Developments
Table 106. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Basic Information
Table 107. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Overview
Table 108. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. General Electric Company (GE Healthcare) Business Overview
Table 110. General Electric Company (GE Healthcare) Recent Developments
Table 111. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Basic Information
Table 112. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Overview
Table 113. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. CEVEC Pharmaceuticals GmbH Business Overview
Table 115. CEVEC Pharmaceuticals GmbH Recent Developments
Table 116. Batavia Biosciences B.V. Viral Vector Production (Research-use) Basic Information
Table 117. Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Overview
Table 118. Batavia Biosciences B.V. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Batavia Biosciences B.V. Business Overview
Table 120. Batavia Biosciences B.V. Recent Developments
Table 121. Biovion oy Viral Vector Production (Research-use) Basic Information
Table 122. Biovion oy Viral Vector Production (Research-use) Product Overview
Table 123. Biovion oy Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Biovion oy Business Overview
Table 125. Biovion oy Recent Developments
Table 126. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Basic Information
Table 127. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Overview
Table 128. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Wuxi AppTec Co., Ltd. Business Overview
Table 130. Wuxi AppTec Co., Ltd. Recent Developments
Table 131. VGXI, Inc. Viral Vector Production (Research-use) Basic Information
Table 132. VGXI, Inc. Viral Vector Production (Research-use) Product Overview
Table 133. VGXI, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. VGXI, Inc. Business Overview
Table 135. VGXI, Inc. Recent Developments
Table 136. Catalent Inc. Viral Vector Production (Research-use) Basic Information
Table 137. Catalent Inc. Viral Vector Production (Research-use) Product Overview
Table 138. Catalent Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Catalent Inc. Business Overview
Table 140. Catalent Inc. Recent Developments
Table 141. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Basic Information
Table 142. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Overview
Table 143. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Miltenyi Biotec GmbH Business Overview
Table 145. Miltenyi Biotec GmbH Recent Developments
Table 146. SIRION Biotech GmbH Viral Vector Production (Research-use) Basic Information
Table 147. SIRION Biotech GmbH Viral Vector Production (Research-use) Product Overview
Table 148. SIRION Biotech GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. SIRION Biotech GmbH Business Overview
Table 150. SIRION Biotech GmbH Recent Developments
Table 151. Virovek Incorporation Viral Vector Production (Research-use) Basic Information
Table 152. Virovek Incorporation Viral Vector Production (Research-use) Product Overview
Table 153. Virovek Incorporation Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Virovek Incorporation Business Overview
Table 155. Virovek Incorporation Recent Developments
Table 156. BioNTech IMFS GmbH Viral Vector Production (Research-use) Basic Information
Table 157. BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Overview
Table 158. BioNTech IMFS GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. BioNTech IMFS GmbH Business Overview
Table 160. BioNTech IMFS GmbH Recent Developments
Table 161. VIVEbiotech S.L. Viral Vector Production (Research-use) Basic Information
Table 162. VIVEbiotech S.L. Viral Vector Production (Research-use) Product Overview
Table 163. VIVEbiotech S.L. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. VIVEbiotech S.L. Business Overview
Table 165. VIVEbiotech S.L. Recent Developments
Table 166. Creative Biogene Viral Vector Production (Research-use) Basic Information
Table 167. Creative Biogene Viral Vector Production (Research-use) Product Overview
Table 168. Creative Biogene Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Creative Biogene Business Overview
Table 170. Creative Biogene Recent Developments
Table 171. Vibalogics GmbH Viral Vector Production (Research-use) Basic Information
Table 172. Vibalogics GmbH Viral Vector Production (Research-use) Product Overview
Table 173. Vibalogics GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Vibalogics GmbH Business Overview
Table 175. Vibalogics GmbH Recent Developments
Table 176. Takara Bio. Viral Vector Production (Research-use) Basic Information
Table 177. Takara Bio. Viral Vector Production (Research-use) Product Overview
Table 178. Takara Bio. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Takara Bio. Business Overview
Table 180. Takara Bio. Recent Developments
Table 181. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Basic Information
Table 182. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Overview
Table 183. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Cell and Gene Therapy Catapult Business Overview
Table 185. Cell and Gene Therapy Catapult Recent Developments
Table 186. BlueBird Bio Viral Vector Production (Research-use) Basic Information
Table 187. BlueBird Bio Viral Vector Production (Research-use) Product Overview
Table 188. BlueBird Bio Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. BlueBird Bio Business Overview
Table 190. BlueBird Bio Recent Developments
Table 191. Addgene, Inc. Viral Vector Production (Research-use) Basic Information
Table 192. Addgene, Inc. Viral Vector Production (Research-use) Product Overview
Table 193. Addgene, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 194. Addgene, Inc. Business Overview
Table 195. Addgene, Inc. Recent Developments
Table 196. Global Viral Vector Production (Research-use) Sales Forecast by Region (2025-2030) & (K Units)
Table 197. Global Viral Vector Production (Research-use) Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 199. North America Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 201. Europe Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Viral Vector Production (Research-use) Sales Forecast by Region (2025-2030) & (K Units)
Table 203. Asia Pacific Viral Vector Production (Research-use) Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 205. South America Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Viral Vector Production (Research-use) Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Viral Vector Production (Research-use) Sales Forecast by Type (2025-2030) & (K Units)
Table 209. Global Viral Vector Production (Research-use) Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Viral Vector Production (Research-use) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 211. Global Viral Vector Production (Research-use) Sales (K Units) Forecast by Application (2025-2030)
Table 212. Global Viral Vector Production (Research-use) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Vector Production (Research-use) Market Size Comparison by Region (M USD)
Table 5. Global Viral Vector Production (Research-use) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viral Vector Production (Research-use) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Vector Production (Research-use) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Vector Production (Research-use) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Production (Research-use) as of 2022)
Table 10. Global Market Viral Vector Production (Research-use) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Vector Production (Research-use) Sales Sites and Area Served
Table 12. Manufacturers Viral Vector Production (Research-use) Product Type
Table 13. Global Viral Vector Production (Research-use) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Vector Production (Research-use)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Vector Production (Research-use) Market Challenges
Table 22. Global Viral Vector Production (Research-use) Sales by Type (K Units)
Table 23. Global Viral Vector Production (Research-use) Market Size by Type (M USD)
Table 24. Global Viral Vector Production (Research-use) Sales (K Units) by Type (2019-2024)
Table 25. Global Viral Vector Production (Research-use) Sales Market Share by Type (2019-2024)
Table 26. Global Viral Vector Production (Research-use) Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Vector Production (Research-use) Market Size Share by Type (2019-2024)
Table 28. Global Viral Vector Production (Research-use) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viral Vector Production (Research-use) Sales (K Units) by Application
Table 30. Global Viral Vector Production (Research-use) Market Size by Application
Table 31. Global Viral Vector Production (Research-use) Sales by Application (2019-2024) & (K Units)
Table 32. Global Viral Vector Production (Research-use) Sales Market Share by Application (2019-2024)
Table 33. Global Viral Vector Production (Research-use) Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Vector Production (Research-use) Market Share by Application (2019-2024)
Table 35. Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 37. Global Viral Vector Production (Research-use) Sales Market Share by Region (2019-2024)
Table 38. North America Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 41. South America Viral Vector Production (Research-use) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viral Vector Production (Research-use) Sales by Region (2019-2024) & (K Units)
Table 43. Merck KGaA Viral Vector Production (Research-use) Basic Information
Table 44. Merck KGaA Viral Vector Production (Research-use) Product Overview
Table 45. Merck KGaA Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck KGaA Business Overview
Table 47. Merck KGaA Viral Vector Production (Research-use) SWOT Analysis
Table 48. Merck KGaA Recent Developments
Table 49. Lonza Viral Vector Production (Research-use) Basic Information
Table 50. Lonza Viral Vector Production (Research-use) Product Overview
Table 51. Lonza Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Business Overview
Table 53. Lonza Viral Vector Production (Research-use) SWOT Analysis
Table 54. Lonza Recent Developments
Table 55. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Basic Information
Table 56. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Product Overview
Table 57. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Viral Vector Production (Research-use) SWOT Analysis
Table 59. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Developments
Table 61. Cobra Biologics Ltd. Viral Vector Production (Research-use) Basic Information
Table 62. Cobra Biologics Ltd. Viral Vector Production (Research-use) Product Overview
Table 63. Cobra Biologics Ltd. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cobra Biologics Ltd. Business Overview
Table 65. Cobra Biologics Ltd. Recent Developments
Table 66. Thermo Fisher Scientific Viral Vector Production (Research-use) Basic Information
Table 67. Thermo Fisher Scientific Viral Vector Production (Research-use) Product Overview
Table 68. Thermo Fisher Scientific Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Waisman Biomanufacturing Viral Vector Production (Research-use) Basic Information
Table 72. Waisman Biomanufacturing Viral Vector Production (Research-use) Product Overview
Table 73. Waisman Biomanufacturing Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Waisman Biomanufacturing Business Overview
Table 75. Waisman Biomanufacturing Recent Developments
Table 76. Genezen Viral Vector Production (Research-use) Basic Information
Table 77. Genezen Viral Vector Production (Research-use) Product Overview
Table 78. Genezen Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Genezen Business Overview
Table 80. Genezen Recent Developments
Table 81. YPOSKESI Viral Vector Production (Research-use) Basic Information
Table 82. YPOSKESI Viral Vector Production (Research-use) Product Overview
Table 83. YPOSKESI Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. YPOSKESI Business Overview
Table 85. YPOSKESI Recent Developments
Table 86. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Basic Information
Table 87. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Product Overview
Table 88. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Business Overview
Table 90. Advanced BioScience Laboratories, Inc. (ABL, Inc.) Recent Developments
Table 91. Novasep Holding S.A.S Viral Vector Production (Research-use) Basic Information
Table 92. Novasep Holding S.A.S Viral Vector Production (Research-use) Product Overview
Table 93. Novasep Holding S.A.S Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novasep Holding S.A.S Business Overview
Table 95. Novasep Holding S.A.S Recent Developments
Table 96. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Basic Information
Table 97. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Product Overview
Table 98. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Business Overview
Table 100. Orgenesis Biotech Israel Ltd (formerly ATVIO Biotech ltd.) Recent Developments
Table 101. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Basic Information
Table 102. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Product Overview
Table 103. Vigene Biosciences, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Vigene Biosciences, Inc. Business Overview
Table 105. Vigene Biosciences, Inc. Recent Developments
Table 106. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Basic Information
Table 107. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Product Overview
Table 108. General Electric Company (GE Healthcare) Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. General Electric Company (GE Healthcare) Business Overview
Table 110. General Electric Company (GE Healthcare) Recent Developments
Table 111. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Basic Information
Table 112. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Product Overview
Table 113. CEVEC Pharmaceuticals GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. CEVEC Pharmaceuticals GmbH Business Overview
Table 115. CEVEC Pharmaceuticals GmbH Recent Developments
Table 116. Batavia Biosciences B.V. Viral Vector Production (Research-use) Basic Information
Table 117. Batavia Biosciences B.V. Viral Vector Production (Research-use) Product Overview
Table 118. Batavia Biosciences B.V. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Batavia Biosciences B.V. Business Overview
Table 120. Batavia Biosciences B.V. Recent Developments
Table 121. Biovion oy Viral Vector Production (Research-use) Basic Information
Table 122. Biovion oy Viral Vector Production (Research-use) Product Overview
Table 123. Biovion oy Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Biovion oy Business Overview
Table 125. Biovion oy Recent Developments
Table 126. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Basic Information
Table 127. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Product Overview
Table 128. Wuxi AppTec Co., Ltd. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Wuxi AppTec Co., Ltd. Business Overview
Table 130. Wuxi AppTec Co., Ltd. Recent Developments
Table 131. VGXI, Inc. Viral Vector Production (Research-use) Basic Information
Table 132. VGXI, Inc. Viral Vector Production (Research-use) Product Overview
Table 133. VGXI, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. VGXI, Inc. Business Overview
Table 135. VGXI, Inc. Recent Developments
Table 136. Catalent Inc. Viral Vector Production (Research-use) Basic Information
Table 137. Catalent Inc. Viral Vector Production (Research-use) Product Overview
Table 138. Catalent Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Catalent Inc. Business Overview
Table 140. Catalent Inc. Recent Developments
Table 141. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Basic Information
Table 142. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Product Overview
Table 143. Miltenyi Biotec GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Miltenyi Biotec GmbH Business Overview
Table 145. Miltenyi Biotec GmbH Recent Developments
Table 146. SIRION Biotech GmbH Viral Vector Production (Research-use) Basic Information
Table 147. SIRION Biotech GmbH Viral Vector Production (Research-use) Product Overview
Table 148. SIRION Biotech GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. SIRION Biotech GmbH Business Overview
Table 150. SIRION Biotech GmbH Recent Developments
Table 151. Virovek Incorporation Viral Vector Production (Research-use) Basic Information
Table 152. Virovek Incorporation Viral Vector Production (Research-use) Product Overview
Table 153. Virovek Incorporation Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Virovek Incorporation Business Overview
Table 155. Virovek Incorporation Recent Developments
Table 156. BioNTech IMFS GmbH Viral Vector Production (Research-use) Basic Information
Table 157. BioNTech IMFS GmbH Viral Vector Production (Research-use) Product Overview
Table 158. BioNTech IMFS GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. BioNTech IMFS GmbH Business Overview
Table 160. BioNTech IMFS GmbH Recent Developments
Table 161. VIVEbiotech S.L. Viral Vector Production (Research-use) Basic Information
Table 162. VIVEbiotech S.L. Viral Vector Production (Research-use) Product Overview
Table 163. VIVEbiotech S.L. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. VIVEbiotech S.L. Business Overview
Table 165. VIVEbiotech S.L. Recent Developments
Table 166. Creative Biogene Viral Vector Production (Research-use) Basic Information
Table 167. Creative Biogene Viral Vector Production (Research-use) Product Overview
Table 168. Creative Biogene Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Creative Biogene Business Overview
Table 170. Creative Biogene Recent Developments
Table 171. Vibalogics GmbH Viral Vector Production (Research-use) Basic Information
Table 172. Vibalogics GmbH Viral Vector Production (Research-use) Product Overview
Table 173. Vibalogics GmbH Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Vibalogics GmbH Business Overview
Table 175. Vibalogics GmbH Recent Developments
Table 176. Takara Bio. Viral Vector Production (Research-use) Basic Information
Table 177. Takara Bio. Viral Vector Production (Research-use) Product Overview
Table 178. Takara Bio. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Takara Bio. Business Overview
Table 180. Takara Bio. Recent Developments
Table 181. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Basic Information
Table 182. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Product Overview
Table 183. Cell and Gene Therapy Catapult Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Cell and Gene Therapy Catapult Business Overview
Table 185. Cell and Gene Therapy Catapult Recent Developments
Table 186. BlueBird Bio Viral Vector Production (Research-use) Basic Information
Table 187. BlueBird Bio Viral Vector Production (Research-use) Product Overview
Table 188. BlueBird Bio Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. BlueBird Bio Business Overview
Table 190. BlueBird Bio Recent Developments
Table 191. Addgene, Inc. Viral Vector Production (Research-use) Basic Information
Table 192. Addgene, Inc. Viral Vector Production (Research-use) Product Overview
Table 193. Addgene, Inc. Viral Vector Production (Research-use) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 194. Addgene, Inc. Business Overview
Table 195. Addgene, Inc. Recent Developments
Table 196. Global Viral Vector Production (Research-use) Sales Forecast by Region (2025-2030) & (K Units)
Table 197. Global Viral Vector Production (Research-use) Market Size Forecast by Region (2025-2030) & (M USD)
Table 198. North America Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 199. North America Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 200. Europe Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 201. Europe Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 202. Asia Pacific Viral Vector Production (Research-use) Sales Forecast by Region (2025-2030) & (K Units)
Table 203. Asia Pacific Viral Vector Production (Research-use) Market Size Forecast by Region (2025-2030) & (M USD)
Table 204. South America Viral Vector Production (Research-use) Sales Forecast by Country (2025-2030) & (K Units)
Table 205. South America Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 206. Middle East and Africa Viral Vector Production (Research-use) Consumption Forecast by Country (2025-2030) & (Units)
Table 207. Middle East and Africa Viral Vector Production (Research-use) Market Size Forecast by Country (2025-2030) & (M USD)
Table 208. Global Viral Vector Production (Research-use) Sales Forecast by Type (2025-2030) & (K Units)
Table 209. Global Viral Vector Production (Research-use) Market Size Forecast by Type (2025-2030) & (M USD)
Table 210. Global Viral Vector Production (Research-use) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 211. Global Viral Vector Production (Research-use) Sales (K Units) Forecast by Application (2025-2030)
Table 212. Global Viral Vector Production (Research-use) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Viral Vector Production (Research-use)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector Production (Research-use) Market Size (M USD), 2019-2030
Figure 5. Global Viral Vector Production (Research-use) Market Size (M USD) (2019-2030)
Figure 6. Global Viral Vector Production (Research-use) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector Production (Research-use) Market Size by Country (M USD)
Figure 11. Viral Vector Production (Research-use) Sales Share by Manufacturers in 2023
Figure 12. Global Viral Vector Production (Research-use) Revenue Share by Manufacturers in 2023
Figure 13. Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Vector Production (Research-use) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Vector Production (Research-use) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Vector Production (Research-use) Market Share by Type
Figure 18. Sales Market Share of Viral Vector Production (Research-use) by Type (2019-2024)
Figure 19. Sales Market Share of Viral Vector Production (Research-use) by Type in 2023
Figure 20. Market Size Share of Viral Vector Production (Research-use) by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Vector Production (Research-use) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Vector Production (Research-use) Market Share by Application
Figure 24. Global Viral Vector Production (Research-use) Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Vector Production (Research-use) Sales Market Share by Application in 2023
Figure 26. Global Viral Vector Production (Research-use) Market Share by Application (2019-2024)
Figure 27. Global Viral Vector Production (Research-use) Market Share by Application in 2023
Figure 28. Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Vector Production (Research-use) Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 32. U.S. Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viral Vector Production (Research-use) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Vector Production (Research-use) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 37. Germany Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viral Vector Production (Research-use) Sales Market Share by Region in 2023
Figure 44. China Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 50. South America Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 51. Brazil Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viral Vector Production (Research-use) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viral Vector Production (Research-use) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viral Vector Production (Research-use) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Vector Production (Research-use) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Vector Production (Research-use) Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Vector Production (Research-use) Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Vector Production (Research-use) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Viral Vector Production (Research-use)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Vector Production (Research-use) Market Size (M USD), 2019-2030
Figure 5. Global Viral Vector Production (Research-use) Market Size (M USD) (2019-2030)
Figure 6. Global Viral Vector Production (Research-use) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Vector Production (Research-use) Market Size by Country (M USD)
Figure 11. Viral Vector Production (Research-use) Sales Share by Manufacturers in 2023
Figure 12. Global Viral Vector Production (Research-use) Revenue Share by Manufacturers in 2023
Figure 13. Viral Vector Production (Research-use) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Vector Production (Research-use) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Vector Production (Research-use) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Vector Production (Research-use) Market Share by Type
Figure 18. Sales Market Share of Viral Vector Production (Research-use) by Type (2019-2024)
Figure 19. Sales Market Share of Viral Vector Production (Research-use) by Type in 2023
Figure 20. Market Size Share of Viral Vector Production (Research-use) by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Vector Production (Research-use) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Vector Production (Research-use) Market Share by Application
Figure 24. Global Viral Vector Production (Research-use) Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Vector Production (Research-use) Sales Market Share by Application in 2023
Figure 26. Global Viral Vector Production (Research-use) Market Share by Application (2019-2024)
Figure 27. Global Viral Vector Production (Research-use) Market Share by Application in 2023
Figure 28. Global Viral Vector Production (Research-use) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Vector Production (Research-use) Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 32. U.S. Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viral Vector Production (Research-use) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Vector Production (Research-use) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 37. Germany Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viral Vector Production (Research-use) Sales Market Share by Region in 2023
Figure 44. China Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 50. South America Viral Vector Production (Research-use) Sales Market Share by Country in 2023
Figure 51. Brazil Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viral Vector Production (Research-use) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viral Vector Production (Research-use) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viral Vector Production (Research-use) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viral Vector Production (Research-use) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viral Vector Production (Research-use) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Vector Production (Research-use) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Vector Production (Research-use) Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Vector Production (Research-use) Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Vector Production (Research-use) Market Share Forecast by Application (2025-2030)
